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OBJECTIVES The purpose of the present study was to assess whether preoperative and postoperative B-type
natriuretic peptide (BNP) levels could be used as predictors of postoperative complications
and outcomes in patients after open-heart surgery.
BACKGROUND A variety of multifactor indexes have been proposed for preoperative risk assessment of
patients undergoing cardiac surgery, but they have shown limited ability and utility in
accurately predicting postoperative complications, hospital stay, and mortality.
METHODS Subjects consisted of 98 male patients (63  9.1 years) undergoing open-heart surgery at the
San Diego Veterans Administration Health System during a 19-month period. B-type
natriuretic peptide levels were analyzed, and postoperative data recorded.
RESULTS There was a higher preoperative BNP level in patients requiring the use of intra-aortic balloon
pumps (IABPs) (mean BNP  387  112 pg/ml vs. 181  25 pg/ml), in patients who died
within one year (357  93 pg/ml vs. 184  26 pg/ml), and in patients with postoperative
hospital stays of 10 days or more (307  68 pg/ml vs. 179  27 pg/ml). Receiver operating
characteristic curves demonstrated preoperative BNP levels as predictors of postoperative
IABP use, hospital stay 10 days, and mortality 1 year with areas under the curve of 0.70,
0.64, and 0.70, respectively. A BNP cut-off value above 385 pg/ml demonstrated high
specificity (90% in each) and accuracy (86%, 79%, 85%, respectively) for predicting each
of these end points.
CONCLUSIONS Preoperative BNP levels 385 pg/ml predict the postoperative complications and one-year
mortality after heart surgery. Postoperatively, elevated peak BNP levels and elevated change
to peak BNP levels were associated with prolonged hospital stay and mortality within one



















spen-heart surgery is associated with significant risk for
ostoperative cardiac events. A variety of multifactorial risk
ndexes have been described to help delineate preoperative
isk assessment of patients undergoing cardiac surgery
1–5). However, their ability to effectively predict postop-
rative complications, hospital stay, and mortality is uncer-
ain, and no gold standard currently exists (6,7). Further-
ore, many of these assessment tools are not routinely
tilized in preoperative evaluation because of complexity,
naccuracy when applied to individuals, unavailability of
mportant variables, and/or time constraints (6,8,9). Some
f these indexes also rely on the clinical judgment of
valuating physicians, introducing potential for wide varia-
ion based on experience and competency (5). A valuable
ddition to the preoperative evaluation would be a quanti-
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ccurately predicting postoperative length of hospital stay,
orbidity, and mortality.
B-type natriuretic peptide (BNP) is a cardiac hormone
hat is synthesized by ventricular myocytes in response to
entricular dysfunction and wall-stress (10). It modulates
lasma volume and myocardial stretch through its actions as
diuretic, a renin-angiotensin-aldosterone system antago-
ist, and as an inhibitor of sympathetic outflow and vaso-
onstrictor production (11). Recent studies have demon-
trated the utility for BNP levels in recognizing and
redicting congestive heart failure (HF) exacerbations in
atients presenting to the emergency department with
yspnea (12,13).
It has previously been demonstrated that, after heart
urgery, BNP correlates with a marker for myocardial
schemia, creatine kinase-MB (14), as well as with recovery
f ventricular function (15). Most of the multivariable risk
ndexes for preoperative assessment use ejection fraction as
major factor in their calculations of risk, and studies have
hown that low ejection fraction alone is one of the best
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BNP Levels and Bypass Surgery May 19, 2004:1873–9ality (16). Therefore, it seems logical that preoperative
NP could be capable of predicting postoperative outcomes
ecause it has been shown to correlate with ejection fraction
nd ventricular dysfunction (17,18).
The purpose of the present study was to assess whether
reoperative and postoperative BNP levels could be used as
redictors of postoperative complications and outcomes in
atients after open-heart surgery. We hypothesized that
atients with high pre- and postoperative BNP levels would
ncounter postoperative complications, prolonged hospital
tay, readmission, and mortality. Likewise, we postulated
hat a quantitative level of BNP exists above which these
dverse clinical end points are likely to occur.
ETHODS
uring the 19-month period (July 2000 to February 2002),
e prospectively recruited 98 male patients, referred to the
an Diego Veterans Affairs Health Care System for open-
eart surgery, in compliance with the Human Research
rotection Program at the University of California, San
iego. All male patients undergoing heart surgery at the
A hospital were eligible for inclusion, and every effort was
ade to recruit them in consecutive order. Female patients
ere excluded because they comprise an insignificant frac-
ion of the VA patient population.
tudy protocol. Patient records were evaluated before
nowledge of BNP values. Past medical and surgical histo-
ies were determined by review of previous records. Echo-
ardiogram and cardiac catheterization data were reported
s by the attending cardiologist. Procedure and intraopera-
ive data were determined by review of finalized surgical
ote and anesthesia record. Cardiac events and clinical end
oints were reported only after review and confirmation by
n attending physician.
Blood samples (5 ml) were obtained from patients pre-
peratively and daily every morning postoperatively until the
atient was discharged from the hospital. Blood was col-
ected into a tube containing potassium EDTA. Samples
ere analyzed for BNP levels using a fluorescence immu-
oassay kit (Biosite Diagnostics, San Diego, California).
he precision and sensitivity of this kit have been previously
escribed (19).
utcome data. Clinical end points included: 1) intraoper-
tive and postoperative cardiac events: significant ST-
egment change, significant arrhythmia, new Q-wave, or
ardiac enzyme elevation; 2) ventilator dependence 48 h
Abbreviations and Acronyms
AUC  area under the curve
BNP  B-type natriuretic peptide
HF  heart failure
IABP  intra-aortic balloon pump
ROC  receiver operating characteristicostoperatively; 3) intensive care unit stay longer than 5 pays postoperatively; 4) hospital stay longer than 10 days
ostoperatively; 5) emergency reintubation other than for
eoperation; 6) cardiothoracic reoperation within 2 weeks of
nitial surgery; 7) readmission within 30 days for cardiac
easons; 8) requirement for intra-aortic balloon pump
IABP); 9) mortality within 30 days and within 1 year
ostoperatively; and 10) postoperative requirement for epi-
ephrine, lidocaine, and/or pressor doses of dopamine.
tatistical analysis. Correlations of preoperative BNP val-
es with other variables were made using Pearson’s corre-
ation. Mean BNP values among groups were compared
sing the Student t test. Median postoperative BNP levels
ere compared using nonparametric Mann-Whitney test.
ll comparisons were calculated using log-transformed
NP concentrations to correct for known intrinsic skew in
istribution. The utility of BNP as a prognostic indicator of
ntraoperative and postoperative complications was evalu-
ted using receiver operating characteristic (ROC) curves.
reoperative ejection fraction, as determined by echocardio-
ram or cardiac catheter ventriculography, was also evalu-
ted for its ability to predict intra- and postoperative
omplications using ROC curves.
ESULTS
he most relevant clinical information for the 98 patients is
hown in Table 1. The mean patient age was 63  9 years.
he mean preoperative ejection fraction was 55%. Nine
atients had New York Heart Association functional class
II or IV symptoms on admission. Seven patients had a
yocardial infarction within six weeks before surgery. Nine
able 1. Patient Characteristics
Patient Data
otal number of patients 98
ge (yrs) 63  9.1
reoperative ejection fraction (%) 55  13
yocardial infarction within 6 weeks
preoperatively (patients)
7
HF NYHA functional class III or IV (patients) 9
nsulin-dependent diabetes mellitus (patients) 10
ast cerebrovascular accident (patients) 10
hronic renal insufficiency (patients) 7
revious percutaneous transluminal coronary
angioplasty/stent (patients)
19





ortic valve replacement 19
itral valve replacement 4




SD  atrial septal defect; CABG  coronary artery bypass grafting; CHF 
ongestive heart failure; NYHA  New York Heart Association; VSD  ventricular
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May 19, 2004:1873–9 BNP Levels and Bypass Surgeryients (n  84) underwent coronary artery bypass grafting,
nd seven patients underwent additional valvular surgery.
Intraoperative and postoperative data, cardiac events, and
he clinical end points are displayed in Table 2. The mean
umber of bypass grafts was 2.3  1.3. Dopamine and/or
pinephrine was infused in almost half of the study group.
idocaine infusion was necessary for seven patients. The
verage postoperative hospital stay was 8.7  11.0 days.
hirty-two patients had some cardiac events, most of which
ere new postoperative arrhythmias including atrial fi-
rillation. Eight patients had significant postoperative
T-segment changes on electrocardiogram, and only one
xperienced a new Q-wave myocardial infarction. Postop-
ratively, 11 patients required intensive care unit stays
onger than five days. Nineteen patients remained in the
ospital for 10 days or more. Thirteen patients were
entilator-dependent for more than 48 h after surgery, and
ve had to be reintubated for respiratory distress. Ten
atients required the use of an IABP. Twelve were read-
itted within a month for cardiac complications, and four
equired reoperation within two weeks. Eleven patients died
ithin 1 year of surgery, and three within 30 days.
Table 3 shows the correlation of preoperative BNP levels
ith features surrounding the perioperative phase. Preoper-
tive ejection fraction, as determined by transthoracic echo-
ardiogram, showed significant positive correlation with
able 2. Clinical End Points
Intra/Postoperative Data Mean  SD
umber of grafts 2.3  1.3
ypass time (min) 133  39
ross-clamp time (min) 83  26
opamine 3 g/kg/min (patients) 46
pinephrine (patients) 26
idocaine (patients) 7
ostoperative hospital stay (days) 8.7  11
Cardiac Events (n  32)
Number of
Patients
ntraoperative ST-segment change 4
ntraoperative arrhythmia 4
ostoperative new Q-wave 1
ostoperative ST-segment change 8
ostoperative arrhythmia 18




CU 5 days postoperatively 11
entilator 2 days 13
eintubation (not for surgery) 5
ntra-aortic balloon pump 10
eoperation 2 weeks (cardiothoracic) 4
eadmission 30 days (cardiac) 12
ortality 30 days 3
ortality 1 yr 11
ardiac event (patients with 1 or more) 32
ostoperative hospital stay 10 days or more 19
CU  intensive care unit.reoperative BNP levels (p  0.05, R  0.25) (Table 3). jection fraction calculated during cardiac catheterization
entriculography did not significantly correlate with preop-
rative BNP. Postoperative days spent in the hospital were
lso significantly correlated with preoperative BNP levels (p
0.05, R  0.20). There was no significant correlation
etween preoperative BNP levels and age, number of
oronary vessels diseased or grafted, time on the cardiopul-
onary bypass machine, or cross-clamp time.
As can be seen in Figure 1, the Student t test demon-
trated a significantly higher mean preoperative BNP level
n patients requiring the use of an IABP (mean BNP 387
112 pg/ml vs. 181 25 pg/ml with no IABP), in patients
ho died within one year (357  93 pg/ml vs. 184  26
g/ml in those alive), and in patients with postoperative
ospital stays of 10 days or more (307  68 pg/ml vs. 179
27 pg/ml with stay 10 days). There were no other
ignificant differences in mean BNP between patient groups
ith and without particular end points.
Figure 2 shows the three ROC curves relating preoper-
tive BNP levels to use of an IABP, postoperative hospital
tay of 10 days or more, and one-year mortality. Figure 2A
isplays a ROC curve for patients who required use of an
able 3. Correlations With Preoperative BNP Levels




ostoperative days in hospital 0.20 0.05
ge 0.07 NS
umber of vessels grafted 0.02 NS




ypass time 0.14 NS
ross-clamp time 0.07 NS
NP  B-type natriuretic peptide; NS  not significant.
igure 1. Preoperative B-type natriuretic peptide (BNP) levels in patients
ith and without particular end points (use of an intra-aortic balloon pump
IABP], mortality [Mort] within one year, and postoperative hospital
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BNP Levels and Bypass Surgery May 19, 2004:1873–9ABP. Three computer-generated BNP cut-points were
xamined, and sensitivity, specificity, positive predictive
alue, negative predictive value, and accuracy were calcu-
igure 2. Receiver operating characteristic curves: preoperative B-type na
ostoperative hospital stay of 10 days or more, and (C) one-year mortalityated. The area under the curve (AUC) for this group was c.70. A preoperative BNP of 385 pg/ml had a sensitivity of
0%, a specificity of 90%, and an accuracy of 86% for
redicting the postoperative use of a pump. The lower BNP
tic peptide (BNP) levels to use of an (A) intra-aortic balloon pump, (B)triure
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May 19, 2004:1873–9 BNP Levels and Bypass Surgeryut less specific and accurate. The ROC curve for BNP as
predictor of postoperative hospital stay of 10 days or more
ad an AUC of 0.64 (Fig. 2B). A preoperative cut-point of
NP of 385 pg/ml had a sensitivity of 32%, a specificity of
0%, and an accuracy of 79% for predicting postoperative
tay. Figure 2C displays the ROC curve for patients who
ied within one year. The AUC for this group was 0.70. A
NP cut-point of 385 pg/ml had a sensitivity of 46%, a
pecificity of 90%, and an accuracy of 85% for predicting
ortality within one year of open-heart surgery. As the data
able displays, the lower cut-off BNP values were more
ensitive, but considerably less specific and less accurate.
he area under the ROC curve for the patients with an
ntensive care unit stay greater than five days was 0.64 (curve
ot shown). However, the significance of this curve was not
ithin acceptable range.
Receiver operating characteristic curves were also exam-
ned to compare preoperative ejection fraction, as deter-
ined by echocardiogram, to the same clinical end points
sed for our preoperative BNP samples. None of these
OC curves demonstrated acceptable significance.
Receiver operating characteristic curve analysis was also used
o determine the relationship between the maximum postop-
rative change in BNP and postoperative events (Fig. 3).
ineteen patients were hospitalized for at least 10 days, and 11
atients in this study died within one year. The sensitivity of
he maximum change in BNP to predict these outcomes was
4% at the level of 531 pg/ml. The negative predictive value of
igure 3. Receiver operating characteristic: change to maximum B-type
atriuretic peptide (BNP) in patients with prolonged hospitalization (10
ays) or death within one year. AUC  area under the curve.he same peak change BNP level was 93%. By use of a cut-off talue of 1,055 pg/ml, the specificity of BNP for prolonged
ospital stay or death within a year was 88%.
Figure 4 shows the highest postoperative BNP level in
elation to prolonged hospital stay and one-year mortality.
here was a significant difference in the highest postoper-
tive BNP levels between the group that was hospitalized
10 days postoperatively and the group that had prolonged
ospital stay for 10 or more days (750 pg/ml vs. 1,190
g/ml, p  0.001). Those two groups also showed highly
ignificant difference in median change to maximum BNP
evels (524 pg/ml vs. 960 pg/ml, p  0.001).
There was also a significant difference in median levels of
he highest postoperative BNP levels in 11 patients deceased
ithin a year (1,265 pg/ml) and in patients that had
ndergone open-heart surgery but were alive after one year
793 pg/ml) (p  0.01).
ISCUSSION
number of risk indexes have been developed in an attempt
igure 4. (A) Highest postoperative B-type natriuretic peptide (BNP)
evels in patients that were alive and group that were deceased within one
ear. p 0.007. (B) Highest postoperative BNP levels in patients that were
ospitalized up to 10 days, and patients that had prolonged hospital stay
10 days) after open-heart surgery. p  0.0001. The ends of the
hiskers show the position of the minimum and maximum of the data,
hereas the edges and line in center of the box show the upper and lower
uartiles and the median. The whiskers show at a glance the behavior of
he extreme outliers, whereas the box edges and midline summarize the
ample in a resistant manner. Strong asymmetry in the box midline and
dges suggests that the distribution is skewed and can be quantified using
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BNP Levels and Bypass Surgery May 19, 2004:1873–9ality in patients undergoing heart surgery. Although these
ndexes have been extensively studied, they have been found
o have questionable predictive value, accuracy, and overall
sability in the clinical setting. Currently, there is no gold
tandard for preoperative risk assessment in heart surgery
atients (5–9). Before this study, preoperative BNP has not
een evaluated for its ability to predict complications in the
ostoperative period after heart surgery, nor has BNP ever
een part of the standard preoperative work-up. Further-
ore, none of the risk assessment indexes incorporate
reoperative BNP levels into their calculations despite its
roven correlation with ventricular dysfunction and ability
o accurately diagnose HF.
Our study demonstrates that preoperative BNP levels
ay provide a novel advance in eliciting risk of open-heart
urgery in male veterans, mainly as a way of predicting
ostoperative length of stay, morbidity, and mortality; BNP
ay be the most accurate above the level of 385 pg/ml in the
reoperative evaluation for heart surgery. Although this
evel of BNP is higher than the cut-point of 100 pg/ml
elineated in the Breathing Not Properly study for making
he diagnosis of congestive HF (20), it is consistent with
rognostic levels found in other studies. Harrison et al. (13)
ound that BNP levels above 480 pg/ml could predict future
ongestive HF events in patients presenting with dyspnea to
he emergency department (480 pg/ml). Chang et al. (21)
ound a 96% negative predictive value for readmission
mong hospitalized patients discharged with a BNP level
420 pg/ml. Bettencourt et al. (22) found that a discharge
NP of 500 pg/ml strongly predicted rehospitalization.
urther prospective studies are needed for validation of the
re-op BNP breakpoint of 385 pg/ml.
It should be noted that preoperative BNP, despite high
pecificity and accuracy, had low sensitivity and positive
redictive value in our study. This suggests that BNP levels
re best used not as a “stand-alone” test, but in conjunction
ith existing multivariable risk indexes.
The areas under the ROC curve for preoperative BNP as
predictor of mortality within one year (0.70) and need for
ABP (0.70) are competitive with the AUC for morbidity
nd mortality demonstrated in Weightman’s study of the
odified Parsonnet’s score (0.70 and 0.70), Higgins score
0.68 and 0.70), Tremblay score (0.68 and 0.67), and Tu
core (0.68 and 0.69). Several studies have compared these
ndexes and others, with most area under ROC curve
nalyses within the range of 0.70 to 0.80 (5–9). As in our
tudy, IABP use and length of hospital stay are some of the
ommon end points used to evaluate morbidity with these
ndexes. It seems promising that a simple preoperative BNP
evel produces ROC curves that are comparable to these
omplex indexes. On the other hand, the risk indexes
sually look at mortality within 30 days, and only our
ne-year mortality curve was significant. Our area under the
OC curve for mortality within 30 days was 0.69, but
aving only three positive subjects in our small study is the
ost likely explanation for this curve’s unacceptable signif-cance. Studies with more statistical power may be indicated
o evaluate BNP’s utility for predicting mortality within 30
ays.
It is interesting that preoperative ejection fractions, al-
hough showing significant correlation with BNP, did not
ield any significant ROC curves when compared with the
linical end points. It is possible that the measured ejection
ractions did not correlate as much as expected with the
reoperative BNP levels because the ejection fractions were
etermined by different methods in our study group (61
ubjects by echocardiogram vs. 37 subjects by ventriculog-
aphy) and, in many cases, several weeks in advance of the
reoperative BNP measurement. With stronger correlation
higher R values), we would predict that the ROC curves for
jection fraction and BNP might be similar. On the other
and, it is possible that this observation is real, and, in our
tudy group, BNP was more sensitive, specific, and accurate
n predicting the clinical end points.
tudy limitations. A limitation of this study was the all-
ale, veteran population. Further studies on larger and more
iverse populations are warranted to compare predictive ability
f preoperative BNP to current multivariable risk indexes and
o evaluate potential for integration of this tool into preoper-
tive evaluation. Also, two different methods were used to
btain the preoperative ejection fraction measurements. Al-
hough expensive and tedious, it would be optimal to obtain
he preoperative ejection fraction using one standard test. This
reoperative ejection fraction should, ideally, be measured at
he same time as the preoperative BNP level—this precise
oordination was not always feasible in our study.
onclusions. In the future, physicians may be able to use
hese quantitative cut-off values in their decision to delay
eart surgery in order to further “tune up” the patient. This
ight be through diuresis, in which case the BNP level
ould be quickly, inexpensively, and quantitatively followed
ntil it reaches more reassuring levels. Even if this tune-up
elays surgery, the physician may be preventing postopera-
ive morbidity (i.e., balloon pumps, prolonged stay) and
remature mortality. In the outpatient setting, BNP-guided
herapy has been shown to be beneficial (23). Alternatively,
f the patients euvolemic BNP is high, the higher patient
isk might be weighed into the decision on whether or not
o proceed with open-heart surgery.
A previous study has shown that a serum marker, tropo-
in I, is useful in detecting postoperative complications
24). Similarly, we demonstrated that postoperative elevated
hange to peak BNP levels predicted prolonged hospital stay
nd death. One might speculate that the combination of a
ecrosis marker (troponin I) and a volume and pressure
arker (BNP) might be useful for further risk stratification
f patients before and in the early postoperative state.
eprint requests and correspondence: Dr. Alan S. Maisel,
AMC Cardiology 111-A, 3350 La Jolla Village Drive, San
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